Zoono Global Analysis
Zoono Global is a biotech company focused on developing, manufacturing, and distributing environmentally-friendly antimicrobial solutions. Established in 2009, Zoono has positioned itself as a pioneer in long-lasting germ protection through its unique 'zoono molecule'. The molecule's ability to bond to various surfaces and eradicate pathogens, including bacteria, viruses, algae, fungi, and mould, has garnered significant attention.
Zoono's comprehensive product range, including sprays, wipes, and foams for skin care, surface sanitization, and mould remediation, has not only received numerous regulatory approvals but has also been validated through independent testing in laboratories worldwide.
Although specific information about its headquarters and recent investments is not available, the company's presence on the Australian Stock Exchange (ASX: ZNO) and its global availability underscores its potential for growth and impact. With its mission to improve health and well-being through innovative, safe, and non-toxic germ protection, Zoono Global presents an intriguing opportunity in the realm of biotech and public health.
For further details, visit www.zoono.com.
There is no investment information
No recent news or press coverage available for Zoono Global.